BREAST CANCER DISEASE AND NEW COMPOUNDS WITH ANTICANCER ACTIVITY
DOI:
https://doi.org/10.56782/pps.53Keywords:
tumour, breast cancer, chemical therapy, 3,3’-diindolylmethaneAbstract
Breast cancer is the most common women’s malignant tumour. Many drugs used in chemotherapy are hazardous because of side-effects, therefore, the search for new active compounds is advisable. 3,3’-diindolilomethane (DIM) is known to inhibit DNA synthesis and cell proliferation in human breast cancer cells. It is a natural product produced during the autolytic breakdown of glucobrassicin, that occurs in Crucifereae (cabbage, Brussels sprouts, cauliflower). At present, in the Department of Organic Chemistry derivates of DIM are synthesised, which could be considered as potential chemotherapeutics.
Downloads
References
Podstawowe informacje o rozwoju demograficznym Polski w 2001 roku, www.stat.gov.pl
Pietrzyk G., Młynarczyk Sz.: Leki współczesnej terapii w Polsce, 2004, 6, 50.
Nebert D.W.: Toxicology, 2002, 181-182, 131. DOI: https://doi.org/10.1016/S0300-483X(02)00269-X
Levine A.J.: Ann. Rev. Biochem., 1993 62, 623. DOI: https://doi.org/10.1146/annurev.bi.62.070193.003203
Pitot H.C.: Cancer, 1982, 49(6), 1206. DOI: https://doi.org/10.1002/1097-0142(19820315)49:6<1206::AID-CNCR2820490623>3.0.CO;2-7
Hollstein M., Sidransky D., Vogelstein B., Harris C.C.: Science, 1991, 253(5015), 49. DOI: https://doi.org/10.1126/science.1905840
Lee E.Y., To H., Shew J.Y., Bookstein R., Scully P., Lee W.H.: Science, 1988, 241(4862), 218. DOI: https://doi.org/10.1126/science.3388033
Yoshida K., Miki Y.: Cancer Sci., 2004 95(11), 866. DOI: https://doi.org/10.1111/j.1349-7006.2004.tb02195.x
Bretsky P. et al.: Cancer Epidemiol. Biomarkers Prev. 2003, 12, 733.
Chazin V.R., Kaleko M., Miller A.D., Slamon D.J.: Oncogene, 1992, 7, 1859.
Menard S., Pupa S.M., Campiglio M., Tagliabue E.: Oncogene, 2003, 22, 6570. DOI: https://doi.org/10.1038/sj.onc.1206779
Pieńkowski T., Jaśkiewicz J., Wronkowski Zb., Zwierko M., Załucki W.: Służba Zdrowia, 2000, 24-26, 2917.
Pharmindex 2003, MediMedia International Sp. z o. o.
Janiec W., Krupińska J.: 1999, "Farmakodynamika" PZWL, Warszawa.
Zając M., Pawełczyk E.: 2000, "Chemia leków" Akademia Medyczna im. Karola Marcinkowskiego, Poznań.
Senkus-Konefka El.: Nowa Med., 2000, 10, 34.
Pieńkowski T., Jagiełło-Gruszfeld Ag.: Nowa Med., 2001, 5/6, 13.
Nawrocki S., Mackiewicz An.: Nowa Med., 2000, 10, 39.
Untch M., Ditsch N., Hermelink K.: Expert Rev. Anticancer Ther., 2003, 3, 403. DOI: https://doi.org/10.1586/14737140.3.3.403
Pietras R.J., Fendly B.M., Chazin V.R., Pegram M.D., Howell S.B., Slamon D.J.: Oncogene, 1994, 9, 1829.
Grose K.R., Bjeldanes L.F.: Chem. Res. Toxicol., 1992, 5, 188. DOI: https://doi.org/10.1021/tx00026a007
McDanell R., McLean A., Hanley A., Heaney R., Fenwick G.: Food Chem. Toxicol., 1988, 26, 59. DOI: https://doi.org/10.1016/0278-6915(88)90042-7
Loub W.D., Wattenberg L.W., Davis D.W.: J. Natl. Cancer Inst., 1975, 54, 985. DOI: https://doi.org/10.1093/jnci/54.4.1005
Wattenberg L.W., Loub W.D.: Cancer Res., 1978, 38, 1410.
Leong H., Firestone G.L., Bjeldanes L.F.: Carcinogenesis, 2001, 22, 1809. DOI: https://doi.org/10.1093/carcin/22.11.1809
Chen D.Z., Qi M., Auborn K.J., Carter T.H.: J. Nutr., 2001, 131, 3294. DOI: https://doi.org/10.1093/jn/131.12.3294
Le H.T., Schaldach Ch.M., Firestone G.L., Bjeldanes L.F.: J. Biol. Chem., 2003, 278, 21136. DOI: https://doi.org/10.1074/jbc.M300588200
Bonnesen Ch., Eggleston I.M., Hayes J.D.: Cancer Res., 2001, 61, 6120.
Hong C., Firestone G.L., Bjeldanes L.F.: Biochem. Pharmacol., 2002, 63, 1085. DOI: https://doi.org/10.1016/S0006-2952(02)00856-0
Hong C., Kim H.A., Firestone G.L., Bjeldanes L.F.: Carcinogenesis, 2002, 23, 1297. DOI: https://doi.org/10.1093/carcin/23.8.1297
Cover C.M., Hsieh S.J., Tran S.H., Hallden G., Kim G.S., Bjeldanes L.F., Firestone G.L.: J Biol Chem., 1998, 273, 3838. DOI: https://doi.org/10.1074/jbc.273.7.3838
Chen I., McDougal A., Wang F., Safe S.: Carcinogenesis, 1998, 19, 1631. DOI: https://doi.org/10.1093/carcin/19.9.1631
Thesing J.: Chem. Ber., 1954, 87, 692. DOI: https://doi.org/10.1002/cber.19540870513
Hellmann H., Lingens F.: Chem. Ber., 1954, 87, 940. DOI: https://doi.org/10.1002/cber.19540870624
Thesing J., Klüssendorf S., Ballach P., Mayer H.: Chem. Ber., 1955, 88, 1295. DOI: https://doi.org/10.1002/cber.19550880824
Henry D.W., Leete E.: J. Am. Chem. Soc., 1957, 79, 5254. DOI: https://doi.org/10.1021/ja01576a051
Singh H., Singh K.: Tetrahedron, 1988, 44, 5897. DOI: https://doi.org/10.1016/S0040-4020(01)81447-2
Suda K., Takanami T.: Chem. Lett., 1994, 10, 1915. DOI: https://doi.org/10.1246/cl.1994.1915
Xie W., Bloomfield K.M., Jin Y., Dolney N.Y., Wang P.G.: Syn. Lett., 1999, 4, 498. DOI: https://doi.org/10.1055/s-1999-2642
Nagarajan R., Perumal P.T.: Chem. Lett., 2004, 33, 288. DOI: https://doi.org/10.1246/cl.2004.288
Maciejewska D., Niemyjska M., Wolska I., Włostowski M., Rasztawicka M.: Z. Naturforsch., 2004, 56b, 1.
Földeák S., Czombos J., Matkovics B., Pórszász J.: Acta Phys. Chem., 1965, 11, 115.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
For all articles published in Prospects in Pharmaceutical Sciences copyright is retained by the authors. The journal publishes articles in the Open Access policy, within the CC BY 4.0 licence.
This is a human-readable summary of (and not a substitute for) the license. Disclaimer.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
How to Cite
